Account
Aircel divides media duties worth Rs 1.8 bn among Starcom Worldwide and Mudra Max
Indiantelevision.com and Spatial Access Solutions‘ newsletter — ‘Ad Accounts Action‘ — that will keep you abreast with all the creative and media accounts changing hands in the industry. Spatial Access Solutions (SAS) is India‘s first media audit firm and hence, has a keen eye on all movements in the space.‘Ad Accounts Action‘ is brought to you once every fortnight. Given below is a listing of accounts that moved in the period 24 November 2011- 07 December 2011. |
Account name | Incumbent | New agency | Reported annual spends in Rs |
| Media | |||
| Aircel | – | Starcom Worldwide | 1.80 billion |
| Mudra Max | |||
| Amar Remedies Ltd [ARL] | MediavVest Worldwide | Lodestar UM | NA |
| Educomp Schools | – | Vizeum [Delhi] | NA |
| Metro Cash & Carry India | – | Lintas media Group [Bangalore] | 200 million |
| SuperMax | – | MediaVest Worldwide | NA |
| WSH‘s Karnataka Lions | – | Katha Mediatix | 20-40 million |
| XS Real | – | Vizeum India [Chennai] | NA |
| Creative | |||
| Anchor Panasonic | – | Scarecrow Communications | NA |
| BIG FM | – | Saints & Warrior | NA |
| Marching Ants | |||
| DLF | – | Scarecrow [Delhi] | NA |
| Fiat | Bates | Saints & Warriors | 600 million |
| IndiaMart | – | Future Uday Communications | 100 million |
| Lavazza | – | Law & Kenneth | NA |
| PassPass | – | Dentsu Marcom | NA |
DS Group‘s new chweing gum | |||
| Shalimar Paints | – | ANC | NA |
| Creative & Media | |||
| Globatt Batteries | Future Uday Cmmunications | 100 million | |
| Ansal API | |||
| Information compiled for period 24 Nov 2011- 07 Dec 2011 by Spatial Access Media Solutions, India‘s first Media Audit & Advisory. For information or clarifications email : info@spatialaccess.com, www.spatialaccess.com | |||
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”
